Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ac607 (1 trial)
allogeneic multipotent stromal cell (1 trial)
autologous mesenchymal stem cells (1 trial)
Acute Kidney Injury (Phase 2)
Kidney Tubular Necrosis, Acute (Phase 1)
Necrosis (Phase 1)
Wounds and Injuries (Phase 2)
Trials (2 total)
Trial APIs (3 total)